DEFECTIVE DRUGS
Parker Waichman Alonso LLP is a leader in defective drug litigation. We are currently evaluating cases involving defective drugs throughout the United States. To view more information involving a specific defective drug, please click on one of the links listed below. Please fill out the form at the right for a free case evaluation by a qualified attorney.
Defective Drugs
Defective Drugs NewsRSS Feed
Another Study Sees Avandia, Actos Fracture Risk
Jul 30, 2010 | Parker Waichman Alonso LLP
Another study has added to the growing body of evidence linking Avandia and Actos to an increased risk of fractures. This latest research, which...
FDA Says Cubicin May Cause Deadly Form of Pneumonia
Jul 29, 2010 | Parker Waichman Alonso LLP
The antibiotic Cubicin (daptomycin) has been associated with life-threatening eosinophilic pneumonia, the U.S. Food & Drug Administration (FDA)...
Glaxo Apologizes for Paid Journal Supplement
Jul 27, 2010 | Parker Waichman Alonso LLP
GlaxoSmithKline has apologized for failing to disclose its role in preparing content for a paid supplement to a medical journal last year. According...
FDA Refers Avandia Panel Conflict Question to HHS
Jul 27, 2010 | Parker Waichman Alonso LLP
Federal drug regulators have referred a potential conflict-of-interest problem on an Avandia advisory panel to the inspector general’s office...
Study Finds Some New Epilepsy Treatments May Up Suicide Risks
Jul 27, 2010 | Parker Waichman Alonso LLP
A recent study has found evidence that the newer epilepsy drugs Keppra, Topamax, and Sabril are associated with a higher risk of suicidal behavior...
Avandia Decision Coming in September, European Regulators Say
Jul 23, 2010 | Parker Waichman Alonso LLP
European regulators will decide by September if Avandia will be allowed to stay on the market there. The European Medicines Agency (EMEA) said...
Glaxo Paxil Birth Defects Settlements Total $1 Billion
Jul 22, 2010 | Parker Waichman Alonso LLP
GlaxoSmithKline (GSK) has agreed to pay in excess of $1 billion to settle hundreds of lawsuits over claims of birth defects linked to Paxil, said...
FDA Details Multiple Violations at Another Johnson & Johnson Plant
Jul 22, 2010 | Parker Waichman Alonso LLP
Federal inspectors found multiple violations at a Johnson & Johnson facility near Lancaster, PA that makes over-the-counter products like...
Tainted Heparin Never Investigated by Chinese Authorities
Jul 22, 2010 | Parker Waichman Alonso LLP
A congressional probe has found that Chinese authorities never bothered to investigate tainted heparin ingredients manufactured in that country, even...
Johnson & Johnson Gets Federal Subpoena Over Recalls
Jul 21, 2010 | Parker Waichman Alonso LLP
A federal grand jury has subpoenaed Johnson & Johnson as part of its investigation into its recent recall of over-the-counter medications....
FDA Halts Avandia Study Enrollment
Jul 21, 2010 | Parker Waichman Alonso LLP
US health regulators have ordered GlaxoSmithKline to stop recruiting patients for an Avandia trail. The trial, called TIDE (Thiazolidinedione...
FDA Advisor Who Voted in Favor of Avandia Had Ties to Glaxo
Jul 20, 2010 | Parker Waichman Alonso LLP
One of the members of a government advisory panel who voted to back Avandia last week was on GlaxoSmithKline’s payroll. According to The Wall...